Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants
Proceedings of the National Academy of Sciences,
Journal Year:
2024,
Volume and Issue:
121(32)
Published: July 30, 2024
Severe
acute
respiratory
syndrome
Coronavirus
2
(SARS-CoV-2)
has
developed
substantial
antigenic
variability.
As
the
majority
of
population
now
pre-existing
immunity
due
to
infection
or
vaccination,
use
experimentally
generated
animal
immune
sera
can
be
valuable
for
measuring
differences
between
virus
variants.
Here,
we
immunized
Syrian
hamsters
by
two
successive
infections
with
one
nine
SARS-CoV-2
Their
were
titrated
against
16
variants,
and
resulting
titers
visualized
using
cartography.
The
map
shows
a
condensed
cluster
containing
all
pre-Omicron
variants
(D614G,
Alpha,
Delta,
Beta,
Mu,
an
engineered
B.1+E484K
variant)
considerably
more
diversity
among
selected
panel
Omicron
subvariants
(BA.1,
BA.2,
BA.4/BA.5,
BA.5
descendants
BF.7
BQ.1.18,
BA.2.75
descendant
BN.1.3.1,
BA.2-derived
recombinants
XBB.2
EG.5.1,
BA.2.86
JN.1).
Some
as
antigenically
distinct
from
each
other
wildtype
is
BA.1
variant.
Compared
measured
in
human
sera,
hamster
are
higher
magnitude,
show
less
fold
change,
result
compact
topology.
results
highlight
potential
continued
characterization
SARS-CoV-2.
Language: Английский
Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 9, 2025
Language: Английский
Covid-19 Vaccine (Nvx-Cov2373 and Nvx-Cov2540) Doses and Virus Strain Match Impact Sex- and Age-Specific Immunity and Protection in Mice
Sabal Chaulagain,
No information about this author
Jaiprasath Sachithanandham,
No information about this author
Jennifer Liu
No information about this author
et al.
Published: Jan. 1, 2025
Language: Английский
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon
Mehdi Benlarbi,
No information about this author
Dell-Dylan Kenfack,
No information about this author
Katrina Dionne
No information about this author
et al.
Virology,
Journal Year:
2025,
Volume and Issue:
605, P. 110467 - 110467
Published: Feb. 25, 2025
Language: Английский
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera
Wei Wang,
No information about this author
Gitanjali Bhushan,
No information about this author
Stephanie Paz
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 6, 2024
Abstract
Antigenic
assessments
of
SARS-CoV-2
variants
inform
decisions
to
update
COVID-19
vaccines.
Primary
infection
sera
are
often
used
for
assessments,
but
such
rare
due
population
immunity
from
infections
and
vaccinations.
Here,
we
show
that
neutralization
titers
breadth
matched
human
hamster
pre-Omicron
variant
primary
correlate
well
generate
similar
antigenic
maps.
The
map
shows
modest
drift
among
XBB
sub-lineage
variants,
with
JN.1
BA.4/BA.5
within
the
cluster,
five
six-fold
differences
between
these
XBB.1.5.
Compared
following
only
ancestral
or
bivalent
vaccinations,
post-vaccination
infections,
XBB.1.5
booster
had
broadest
against
although
a
five-fold
titer
difference
was
still
observed
variants.
These
findings
suggest
antibody
coverage
antigenically
divergent
could
be
improved
vaccine
antigen.
Language: Английский
A quadri-fluorescence SARS-CoV-2 pseudovirus system for efficient antigenic characterization of multiple circulating variants
Cell Reports Methods,
Journal Year:
2024,
Volume and Issue:
4(9), P. 100856 - 100856
Published: Sept. 1, 2024
Language: Английский
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1
Wei Wang,
No information about this author
Gitanjali Bhushan,
No information about this author
Stephanie Paz
No information about this author
et al.
Journal of Virology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 4, 2024
ABSTRACT
Antigenic
assessments
of
SARS-CoV-2
variants
inform
decisions
to
update
COVID-19
vaccines.
Primary
infection
sera
are
often
used
for
assessments,
but
such
rare
due
population
immunity
from
infections
and
vaccinations.
Here,
we
show
that
neutralization
titers
breadth
matched
human
hamster
pre-Omicron
variant
primary
correlate
well
generate
similar
antigenic
maps.
The
map
shows
modest
drift
among
XBB
sub-lineage
variants,
with
JN.1
BA.4/BA.5
within
the
cluster,
fivefold
sixfold
differences
between
these
XBB.1.5.
Compared
following
only
ancestral
or
bivalent
vaccinations,
post-vaccination
infections,
XBB.1.5
booster
had
broadest
against
although
a
titer
difference
was
still
observed
variants.
These
findings
suggest
antibody
coverage
antigenically
divergent
could
be
improved
vaccine
antigen.
IMPORTANCE
Updates
antigens
depend
on
assessing
how
much
differ
newer
Human
single
ideal
discriminating
now
high
immunity.
It
remains
unclear
whether
experimentally
infected
animals
substitute
assessments.
This
report
variant-matched
recognize
similarly,
indicating
can
proxy
We
further
an
broadly
neutralized
were
lower
more
recent
variant.
support
updating
current
composition
developing
framework
in
future
using
sera.
Language: Английский
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Sept. 27, 2023
Abstract
The
antigenic
evolution
of
SARS-CoV-2
requires
ongoing
monitoring
to
judge
the
immune
escape
newly
arising
variants.
A
surveillance
system
necessitates
an
understanding
differences
in
neutralization
titers
measured
different
assays
and
using
human
animal
sera.
We
compared
18
datasets
generated
human,
hamster,
mouse
sera,
six
assays.
Titer
magnitude
was
lowest
intermediate
highest
Fold
change,
immunodominance
patterns
maps
were
similar
among
Most
yielded
results,
except
for
fold
change
cytopathic
effect
Not
enough
data
available
conclusively
judging
but
hamster
sera
a
consistent
surrogate
first-infection
Language: Английский
Antigenic Imprinting Dominates Humoral Responses to New Variants of SARS-CoV-2 in a Hamster Model of COVID-19
Joran Degryse,
No information about this author
Elke Maas,
No information about this author
Ria Lassaunière
No information about this author
et al.
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(12), P. 2591 - 2591
Published: Dec. 14, 2024
The
emergence
of
SARS-CoV-2
variants
escaping
immunity
challenges
the
efficacy
current
vaccines.
Here,
we
investigated
humoral
recall
responses
and
vaccine-mediated
protection
in
Syrian
hamsters
immunized
with
third-generation
Comirnaty®
Omicron
XBB.1.5-adapted
COVID-19
mRNA
vaccine,
followed
by
infection
either
antigenically
closely
(EG.5.1)
or
distantly
related
(JN.1)
subvariants.
Vaccination
YF17D
vector
encoding
a
modified
Gamma
spike
(YF-S0*)
served
as
control
for
restricted
to
pre-Omicron
variants.
Our
results
show
that
both
XBB.1.5
YF-S0*
induce
robust,
however,
poorly
cross-reactive,
neutralizing
antibody
(nAb)
responses.
In
case,
total
nAb
levels
increased
following
infection.
Intriguingly,
specificity
these
boosted
nAbs
did
not
match
respective
challenge
virus,
but
was
skewed
towards
primary
antigen
used
immunization,
suggesting
marked
impact
antigenic
imprinting,
confirmed
cartography.
Furthermore,
limited
cross-reactivity
rapid
decline
induced
EG.5.1
and,
more
concerning,
JN.1,
raises
doubts
about
sustained
vaccine
against
recent
circulating
conclusion,
demonstrate
imprinting
plays
dominant
role
shaping
emerging
Future
design
may
have
address
two
major
issues:
(i)
overcoming
original
sin
limits
breadth
protective
response
variants,
(ii)
achieving
lasts
at
least
one
season.
Language: Английский
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories
Viruses,
Journal Year:
2024,
Volume and Issue:
16(12), P. 1936 - 1936
Published: Dec. 18, 2024
Setting
up
a
global
SARS-CoV-2
surveillance
system
requires
an
understanding
of
how
virus
isolation
and
propagation
practices,
use
animal
or
human
sera,
different
neutralisation
assay
platforms
influence
assessment
antigenicity.
In
this
study,
with
the
contribution
15
independent
laboratories
across
all
WHO
regions,
we
carried
out
controlled
analysis
using
first
International
Standard
for
antibodies
to
variants
concern
(source:
NIBSC).
Live
isolates
BioHub
individual
labs)
spike
plasmids
(individual
pseudovirus
production
were
used
perform
assays
same
serum
panels.
When
comparing
fold
drops,
excellent
data
consistency
was
observed
labs
common
reagents,
including
between
live
(RMSD
from
mean
drop
0.59).
Utilising
Bayesian
model,
geometric
titres
titre
magnitudes
(offsets)
can
describe
efficiently.
Titre
seen
vary
largely
even
within
group.
We
have
that
overall,
Microneutralisation
tend
lowest
titres,
whereas
Pseudovirus
Neutralisation
highest
(with
difference
3.2
log2
units
two).
These
findings
are
relevant
laboratory
networks,
such
as
Coronavirus
Laboratory
Network
(CoViNet),
seek
support
evolution
antigenic
characterisation
monitoring
population
immunity
vaccine
composition
policy.
Language: Английский